Phase
Condition
Asperger's Disorder
Autism
Williams Syndrome
Treatment
Placebo Non-invasive Neuromodulation
Non-invasive Neuromodulation
Clinical Study ID
Ages 2-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Children with a diagnosis of Autistic Spectrum Disorder, attending school in theCity of San Juan de Dios in Las Palmas de Gran Canaria.
Children with symptoms related to sleep disturbances.
Children who present episodes of disruptive behaviour.
Children who may present sensory alterations or cognitive deficits.
Children whose parents sign the informed consent form.
Exclusion
Exclusion Criteria:
Present some of the contraindications for treatment with NESA XSIGNAL®: pacemakers,internal haemorrhages, not applying electrodes on skin in poor condition, withulcerations or wounds, acute febrile processes, acute thrombophlebitis and/or phobiaof electricity.
If parents do not sign the informed consent form.
Presence of uncontrolled convulsions.
Study Design
Study Description
Connect with a study center
University of Las Palmas de Gran Canaria
Las Palmas de Gran Canaria, Las Palmas 35016
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.